Tucson, Arizona-based Picard, the company behind the Syncardia Total Artificial Heart (TAH), received U.S. Patent No. 12,383,722 B2. It covers systems and methods related to the next-generation TAH, the “Emperor.”

Picard recently completed an IPO to support market expansion and plans to fund R&D activities, including those related to the Emperor. The company designed the Emperor as a fully implantable, driverless version of the Syncardia TAH. It provides pulsatile flow without requiring a pneumatic driver.